UiPath (PATH) 10-Q 5 Dec 22 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2022	Dec. 01, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		470,382,453
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Current assets
Cash and cash equivalents	$ 1,451,152	$ 1,768,723
Marketable securities	225,605	96,417
Accounts receivable, net of allowance for doubtful accounts of $3,279 and $2,566, respectively	275,935	251,988
Contract assets	91,551	74,831
Deferred contract acquisition costs	40,168	29,926
Prepaid expenses and other current assets	74,834	55,416
Total current assets	2,159,245	2,277,301
Marketable securities, non-current	2,920	19,523
Contract assets, non-current	9,498	2,730
Deferred contract acquisition costs, non-current	113,568	100,224
Property and equipment, net	28,152	17,176
Operating lease right-of-use assets	50,555	48,953
Intangible assets, net	23,993	16,817
Goodwill	83,844	53,564
Deferred tax asset	7,657	10,628
Other assets, non-current	32,252	25,534
Total assets	2,511,684	2,572,450
Current liabilities
Accounts payable	11,253	11,515
Accrued expenses and other current liabilities	78,892	87,958
Accrued compensation and employee benefits	98,086	130,673
Deferred revenue	288,412	297,355
Total current liabilities	476,643	527,501
Deferred revenue, non-current	107,633	68,665
Operating lease liabilities, non-current	55,085	49,843
Other liabilities, non-current	12,499	4,524
Total liabilities	651,860	650,533
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized as of October 31, 2022 and January 31, 2022; 0 shares issued and outstanding as of October 31, 2022 and January 31, 2022	0	0
Additional paid-in capital	3,649,474	3,406,959
Accumulated other comprehensive income	6,953	10,899
Accumulated deficit	(1,796,609)	(1,495,946)
Total stockholders’ equity	1,859,824	1,921,917
Total liabilities and stockholders’ equity	2,511,684	2,572,450
Class A Common Stock
Stockholders' equity
Common stock	5	4
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Accounts receivable, allowance for doubtful accounts	$ 3,279	$ 2,566
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, shares issued (in shares)	469,924,000	458,773,000
Common stock, shares outstanding (in shares)	469,924,000	458,773,000
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741,000	115,741,000
Common stock, shares issued (in shares)	82,453,000	82,453,000
Common stock, shares outstanding (in shares)	82,453,000	82,453,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue:
Total revenue	$ 262,744	$ 220,816	$ 750,032	$ 602,554
Cost of revenue:
Total cost of revenue	42,768	43,100	132,360	127,704
Gross profit	219,976	177,716	617,672	474,850
Operating expenses:
Sales and marketing	156,469	172,906	527,798	522,925
Research and development	67,341	61,559	203,880	212,245
General and administrative	63,157	59,498	189,130	189,747
Total operating expenses	286,967	293,963	920,808	924,917
Operating loss	(66,991)	(116,247)	(303,136)	(450,067)
Interest income	9,561	899	15,057	2,606
Other income (expense), net	888	(4,300)	(2,523)	(8,743)
Loss before income taxes	(56,542)	(119,648)	(290,602)	(456,204)
Provision for income taxes	1,182	3,139	10,061	6,272
Net loss	$ (57,724)	$ (122,787)	$ (300,663)	$ (462,476)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.10)	$ (0.23)	$ (0.55)	$ (1.08)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.10)	$ (0.23)	$ (0.55)	$ (1.08)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	550,164	531,718	546,087	426,811
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	550,164	531,718	546,087	426,811
Licenses
Revenue:
Total revenue	$ 118,175	$ 111,608	$ 338,875	$ 307,371
Cost of revenue:
Total cost of revenue	3,208	2,626	7,915	7,514
Subscription services
Revenue:
Total revenue	130,159	97,963	370,309	265,924
Cost of revenue:
Total cost of revenue	20,578	15,659	63,949	42,076
Professional services and other
Revenue:
Total revenue	14,410	11,245	40,848	29,259
Cost of revenue:
Total cost of revenue	$ 18,982	$ 24,815	$ 60,496	$ 78,114

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (57,724)	$ (122,787)	$ (300,663)	$ (462,476)
Other comprehensive (loss) income, net of tax:
Unrealized loss on available-for-sale marketable securities, net	(324)	(81)	(625)	(72)
Foreign currency translation adjustments	(3,873)	8,510	(3,321)	16,424
Other comprehensive (loss) income, net	(4,197)	8,429	(3,946)	16,352
Comprehensive loss	$ (61,921)	$ (114,358)	$ (304,609)	$ (446,124)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) shares in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2021	294,257
Beginning balance at Jan. 31, 2021	$ 1,221,968,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net of issuance costs (in shares)	12,043
Issuance of convertible preferred stock, net of issuance costs	$ 749,836,000
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)	(306,300)
Conversion of convertible preferred stock to common stock upon initial public offering	$ (1,971,804,000)
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)				306,300
Conversion of convertible preferred stock to common stock upon initial public offering	$ 1,971,804,000			$ 3,000		$ 1,971,801,000
Ending balance (in shares) at Apr. 30, 2021	0
Ending balance at Apr. 30, 2021	$ 0
Beginning balance (in shares) at Jan. 31, 2021				75,177	110,653
Beginning balance at Jan. 31, 2021	(803,704,000)			$ 1,000	$ 1,000	179,175,000	$ (12,521,000)	$ (970,360,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)				306,300
Conversion of convertible preferred stock to common stock upon initial public offering	1,971,804,000			$ 3,000		1,971,801,000
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs (in shares)				13,000
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs	687,903,000					687,903,000
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)				28,200	(28,200)
Issuance of common stock upon exercise of stock options (in shares)				1,881
Issuance of common stock upon exercise of stock options	3,114,000					3,114,000
Vesting of early exercised stock options	1,646,000					1,646,000
Issuance of common stock upon settlement of restricted stock units (in shares)				389
Tax withholdings on settlement of restricted stock units (in shares)				(164)
Tax withholdings on settlement of restricted stock units	(9,218,000)					(9,218,000)
Shares issued as consideration for business acquisition (in shares)				543
Shares issued as consideration for business acquisition	30,446,000					30,446,000
Stock-based compensation	252,986,000					252,986,000
Other comprehensive income (loss), net of tax	4,227,000						4,227,000
Net loss	(239,663,000)							(239,663,000)
Ending balance (in shares) at Apr. 30, 2021				425,326	82,453
Ending balance at Apr. 30, 2021	$ 1,899,541,000			$ 4,000	$ 1,000	3,117,853,000	(8,294,000)	(1,210,023,000)
Beginning balance (in shares) at Jan. 31, 2021	294,257
Beginning balance at Jan. 31, 2021	$ 1,221,968,000
Beginning balance (in shares) at Jan. 31, 2021				75,177	110,653
Beginning balance at Jan. 31, 2021	(803,704,000)			$ 1,000	$ 1,000	179,175,000	(12,521,000)	(970,360,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss), net of tax	16,352,000
Net loss	(462,476,000)	$ (364,403,000)	$ (98,073,000)
Ending balance (in shares) at Oct. 31, 2021				442,357	82,453
Ending balance at Oct. 31, 2021	$ 1,883,405,000			$ 4,000	$ 1,000	3,312,405,000	3,831,000	(1,432,836,000)
Beginning balance (in shares) at Apr. 30, 2021	0
Beginning balance at Apr. 30, 2021	$ 0
Beginning balance (in shares) at Apr. 30, 2021				425,326	82,453
Beginning balance at Apr. 30, 2021	1,899,541,000			$ 4,000	$ 1,000	3,117,853,000	(8,294,000)	(1,210,023,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				2,993
Issuance of common stock upon exercise of stock options	3,537,000					3,537,000
Vesting of early exercised stock options	615,000					615,000
Issuance of common stock upon settlement of restricted stock units (in shares)				2,492
Tax withholdings on settlement of restricted stock units (in shares)				(18)
Tax withholdings on settlement of restricted stock units	(1,175,000)					(1,175,000)
Shares issued as consideration for business acquisition	21,000					21,000
Stock-based compensation	92,744,000					92,744,000
Other comprehensive income (loss), net of tax	3,696,000						3,696,000
Net loss	(100,026,000)							(100,026,000)
Ending balance (in shares) at Jul. 31, 2021				430,793	82,453
Ending balance at Jul. 31, 2021	1,898,953,000			$ 4,000	$ 1,000	3,213,595,000	(4,598,000)	(1,310,049,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				2,848
Issuance of common stock upon exercise of stock options	3,209,000					3,209,000
Vesting of early exercised stock options	462,000					462,000
Issuance of common stock upon settlement of restricted stock units (in shares)				8,720
Tax withholdings on settlement of restricted stock units (in shares)				(4)
Tax withholdings on settlement of restricted stock units	(199,000)					(199,000)
Stock-based compensation	95,338,000					95,338,000
Other comprehensive income (loss), net of tax	8,429,000						8,429,000
Net loss	(122,787,000)	$ (103,747,000)	$ (19,040,000)					(122,787,000)
Ending balance (in shares) at Oct. 31, 2021				442,357	82,453
Ending balance at Oct. 31, 2021	1,883,405,000			$ 4,000	$ 1,000	3,312,405,000	3,831,000	(1,432,836,000)
Beginning balance at Jan. 31, 2022	0
Beginning balance (in shares) at Jan. 31, 2022		458,773	82,453	458,773	82,453
Beginning balance at Jan. 31, 2022	1,921,917,000			$ 4,000	$ 1,000	3,406,959,000	10,899,000	(1,495,946,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,283
Issuance of common stock upon exercise of stock options	2,683,000					2,683,000
Vesting of early exercised stock options	1,355,000					1,355,000
Issuance of common stock upon settlement of restricted stock units (in shares)				3,499
Tax withholdings on settlement of restricted stock units (in shares)				(1,125)
Tax withholdings on settlement of restricted stock units	(24,827,000)					(24,827,000)
Stock-based compensation	102,085,000					102,085,000
Other comprehensive income (loss), net of tax	(458,000)						(458,000)
Net loss	(122,561,000)							(122,561,000)
Ending balance (in shares) at Apr. 30, 2022				462,430	82,453
Ending balance at Apr. 30, 2022	1,880,194,000			$ 4,000	$ 1,000	3,488,255,000	10,441,000	(1,618,507,000)
Beginning balance at Jan. 31, 2022	0
Ending balance at Oct. 31, 2022	0
Beginning balance (in shares) at Jan. 31, 2022		458,773	82,453	458,773	82,453
Beginning balance at Jan. 31, 2022	$ 1,921,917,000			$ 4,000	$ 1,000	3,406,959,000	10,899,000	(1,495,946,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	3,788
Charitable donation of Class A common stock (in shares)				300
Repurchase of unvested early exercised stock options (in shares)				(400)
Other comprehensive income (loss), net of tax	$ (3,946,000)
Net loss	(300,663,000)	$ (255,266,000)	$ (45,397,000)
Ending balance (in shares) at Oct. 31, 2022		469,924	82,453	469,924	82,453
Ending balance at Oct. 31, 2022	1,859,824,000			$ 5,000	$ 1,000	3,649,474,000	6,953,000	(1,796,609,000)
Beginning balance (in shares) at Apr. 30, 2022				462,430	82,453
Beginning balance at Apr. 30, 2022	1,880,194,000			$ 4,000	$ 1,000	3,488,255,000	10,441,000	(1,618,507,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,418
Issuance of common stock upon exercise of stock options	1,878,000					1,878,000
Issuance of common stock upon settlement of restricted stock units (in shares)				3,183
Issuance of common stock upon settlement of restricted stock units	1,000			$ 1,000
Tax withholdings on settlement of restricted stock units (in shares)				(1,040)
Tax withholdings on settlement of restricted stock units	(18,922,000)					(18,922,000)
Charitable donation of Class A common stock (in shares)				300
Charitable donation of Class A common stock	5,499,000					5,499,000
Shares issued as consideration for business acquisition (in shares)				570
Shares issued as consideration for business acquisition	2,965,000					2,965,000
Issuance of common stock under employee stock purchase plan (in shares)				578
Issuance of common stock under employee stock purchase plan	9,070,000					9,070,000
Repurchase of unvested early exercised stock options (in shares)				(441)
Stock-based compensation	88,533,000					88,533,000
Other comprehensive income (loss), net of tax	709,000						709,000
Net loss	(120,378,000)							(120,378,000)
Ending balance (in shares) at Jul. 31, 2022				466,998	82,453
Ending balance at Jul. 31, 2022	1,849,549,000			$ 5,000	$ 1,000	3,577,278,000	11,150,000	(1,738,885,000)
Ending balance at Oct. 31, 2022	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,087
Issuance of common stock upon exercise of stock options	2,889,000					2,889,000
Issuance of common stock upon settlement of restricted stock units (in shares)				2,790
Tax withholdings on settlement of restricted stock units (in shares)				(951)
Tax withholdings on settlement of restricted stock units	(11,998,000)					(11,998,000)
Stock-based compensation	81,305,000					81,305,000
Other comprehensive income (loss), net of tax	(4,197,000)						(4,197,000)
Net loss	(57,724,000)	$ (49,073,000)	$ (8,651,000)					(57,724,000)
Ending balance (in shares) at Oct. 31, 2022		469,924	82,453	469,924	82,453
Ending balance at Oct. 31, 2022	$ 1,859,824,000			$ 5,000	$ 1,000	$ 3,649,474,000	$ 6,953,000	$ (1,796,609,000)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities
Net loss		$ (300,663)	$ (462,476)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		12,993	10,697
Amortization of deferred contract acquisition costs		37,967	19,904
Net amortization of premium on marketable securities		501	1,391
Stock-based compensation expense		270,797	438,551
Charitable donation of Class A common stock		5,499	0
Amortization of operating lease right-of-use assets		8,555	6,013
Provision for deferred income taxes		1,171	(357)
Abandonment and impairment charges		2,881	0
Other non-cash (credits) charges, net	[1]	(1,714)	1,599
Changes in operating assets and liabilities:
Accounts receivable		(33,449)	(27,028)
Contract assets		(27,735)	(29,994)
Deferred contract acquisition costs		(69,657)	(80,720)
Prepaid expenses and other assets		(27,361)	(2,295)
Accounts payable		2,414	17,549
Accrued expense and other liabilities		(13,785)	17,756
Accrued compensation and employee benefits		(26,096)	(822)
Operating lease liabilities, net		(488)	(5,261)
Deferred revenue		54,232	46,544
Net cash used in operating activities		(103,938)	(48,949)
Cash flows from investing activities
Purchases of marketable securities		(204,311)	(161,214)
Sales of marketable securities		0	89,383
Maturities of marketable securities		93,298	58,109
Purchases of property and equipment		(21,614)	(5,719)
Capitalization of software development costs		0	(2,950)
Payments related to business acquisitions, net of cash acquired		(29,542)	(5,498)
Other investing, net		(507)	(1,231)
Net cash used in investing activities		(162,676)	(29,120)
Cash flows from financing activities
Proceeds from exercise of stock options		7,605	9,687
Payments of tax withholdings on net settlement of equity awards		(53,300)	(10,300)
Net (payments) receipts of tax withholdings on sell-to-cover equity award transactions		(10,132)	20,418
Proceeds from employee stock purchase plan contributions		13,525	13,766
Repurchase of unvested early exercised stock options		(1,493)	0
Proceeds from initial public offering, net of underwriting discounts and commissions		0	692,369
Payments of initial public offering costs		0	(3,734)
Proceeds from issuance of convertible preferred stock		0	750,000
Payments of issuance costs for convertible preferred stock		0	(164)
Net cash (used in) provided by financing activities		(43,795)	1,472,042
Effect of exchange rate changes		(7,162)	11,254
Net (decrease) increase in cash, cash equivalents and restricted cash		(317,571)	1,405,227
Cash, cash equivalents, and restricted cash - beginning of period		1,768,723	371,190
Cash, cash equivalents, and restricted cash - end of period		1,451,152	1,776,417
Supplemental disclosure of cash flow information
Cash paid for interest		720	512
Cash paid for income taxes		19,060	6,680
Supplemental disclosure of non-cash investing and financing activities
Stock-based compensation capitalized for software development		0	4,487
Value of shares issued in payment of business acquisitions		2,965	30,467
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options		1,355	2,723
Payable for marketable securities purchase		2,894	0
Deferred payments related to business acquisitions		11,433	0
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid		$ 2,517	$ 445
[1](1) Prior period amounts have been combined to conform to current presentation

Organization and Description of

Organization and Description of Business	9 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was founded in Bucharest, Romania in 2005, was incorporated in Delaware in June 2015, and is headquartered in New York, New York. We offer an end-to-end automation platform which provides a range of robotic process automation (“RPA”) solutions via a suite of interrelated software offerings that allow our customers to discover automation opportunities and to build, manage, run, engage, measure, and govern automations across departments within an organization. We derive revenue primarily from the sale of: (1) software licenses for use of our proprietary software and related maintenance and support; (2) the right to access certain software products we host (i.e., software as a service, or "SaaS"); (3) hybrid solutions (which are comprised of three types of performance obligations: term license, maintenance and support, and SaaS); and (4) professional services. We have legal presence in 32 countries, with our principal operations in the United States, Romania, and Japan.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Our significant accounting policies are discussed in greater detail in Note 2, Summary of Significant Accounting Policies , in the notes to consolidated financial statements included in the 2022 Form 10-K. There have been no significant changes to these policies during the nine months ended October 31, 2022. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2022, which are included in the 2022 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as the our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its wholly owned subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the nine months ended October 31, 2022 and 2021 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2023 or for any other future interim or annual period. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2023, for example, refer to the fiscal year ending January 31, 2023. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, revenue recognition, estimated expected benefit period for deferred contract acquisition costs, allowance for doubtful accounts, fair value of financial assets, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets, incremental borrowing rates for operating leases, amount of stock-based compensation expense including determination of fair value of common stock prior to our initial public offering ("IPO"), timing and amount of contingencies, costs related to our restructuring actions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions. Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended October 31, 2022 and 2021, we recognized transaction losses of $0.4 million and $6.5 million, respectively. For the nine months ended October 31, 2022 and 2021, we recognized transaction losses of $2.6 million and $11.7 million, respectively. Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of October 31, 2022 and January 31, 2022, 99% and 96%, respectively, of our cash and cash equivalents were concentrated in the United States, European Union (“EU”) countries, and Japan. We extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three and nine months ended October 31, 2022 and 2021, no single customer accounted for 10% or more of our total revenue. As of October 31, 2022, one customer accounted for 11% of our accounts receivable. As of January 31, 2022, no single customer accounted for 10% or more of our accounts receivable. Internal-Use Software Pursuant to Accounting Standards Codification ("ASC") 350-40, Internal Use Software , we capitalize costs incurred to implement cloud computing arrangements that are service contracts and costs incurred to develop internal-use software, which has historically included our SaaS products. ASC 350-40 prescribes capitalization of costs incurred during the application development stage, costs incurred to develop or obtain software that allows for access to or conversion of old data by new systems, and costs incurred in connection with upgrades and enhancements to internal-use software if it is probable that such expenditures will result in additional functionality. These capitalized costs exclude training costs, project management costs, and data migration costs. We evaluate our long-lived assets, including these capitalized costs, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. Beginning in the fourth quarter of fiscal 2022, we began to broadly market on-premises versions of certain of our SaaS products, thereby establishing a pattern of marketing internal-use software and a rebuttable presumption that we intend to market any SaaS products we develop. As a result, our ongoing and future SaaS projects must be accounted for under ASC 985-20, Costs of Software to be Sold, Leased or Marketed , which is discussed below under Software Development Costs . Prior to the fourth quarter of fiscal 2022, costs incurred to develop our SaaS products were capitalized and amortized on a straight-line basis over the product’s estimated useful life of five years; amortization is included in cost of subscription services revenue on the condensed consolidated statements of operations. Capitalized costs included salaries, benefits, and stock-based compensation charges for employees that were directly involved in developing our SaaS products. These capitalized costs are included in other assets, non-current on the condensed consolidated balance sheets. Gross capitalized internal-use software development costs were $7.8 million and $10.1 million as of October 31, 2022 and January 31, 2022, respectively. Related amortization expense was $0.3 million and $0.3 million for the three months ended October 31, 2022 and 2021, respectively. Related amortization expense was $1.0 million and $0.8 million for the nine months ended October 31, 2022 and 2021, respectively. Accumulated amortization was $2.6 million and $1.7 million as of October 31, 2022 and January 31, 2022, respectively. Capitalized costs related to the implementation of cloud computing arrangements that are service contracts are amortized on a straight-line basis over the terms of the associated hosting arrangements and are recorded under operating expenses in the same line item on the condensed consolidated statements of operations as the associated hosting arrangement fees. These gross capitalized costs were $2.1 million and $2.3 million as of October 31, 2022 and January 31, 2022, respectively, and are recorded in other assets, non-current on our condensed consolidated balance sheets. Related amortization expense was $0.1 million and $0.2 million for the three months ended October 31, 2022 and 2021, respectively. Related amortization expense was $0.5 million and $0.6 million for the nine months ended October 31, 2022 and 2021, respectively. Accumulated amortization was $1.7 million and $1.2 million as of October 31, 2022 and January 31, 2022, respectively. Software Development Costs We account for costs incurred to develop software to be licensed in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed . This guidance requires that all costs incurred to establish technological feasibility be expensed as they are incurred. Technological feasibility is established when the working model is complete. Production costs incurred subsequent to establishing technological feasibility are capitalized until the product is available for general release to customers, at which point they are amortized on a product by product basis. Capitalized costs are included in other assets, non-current on the condensed consolidated balance sheets. These costs are amortized over the estimated useful life of the software, which is five years, on a straight-line basis, and are included in cost of licenses revenue or cost of subscription services revenue in the condensed consolidated statements of operations, based on the nature of the underlying product. Management evaluates the useful life of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. Gross capitalized software development costs were $4.1 million and $4.3 million as of October 31, 2022 and January 31, 2022, respectively. Amortization expense was $0.2 million and $0.1 million for the three months ended October 31, 2022 and 2021, respectively. Related amortization expense was $0.6 million and $0.4 million for the nine months ended October 31, 2022 and 2021, respectively. Accumulated amortization was $1.8 million and $1.2 million as of October 31, 2022 and January 31, 2022, respectively. During the nine months ended October 31, 2022, software development costs incurred during the time period between establishment of technological feasibility and general release were not material and accordingly were expensed as incurred. Business Acquisitions Purchase consideration in a business combination is allocated to the assets acquired and liabilities assumed, based on their respective fair values at the date of the acquisition. Determination of the fair value of assets acquired and liabilities assumed relies on management judgments and involves the use of estimates and assumptions, including but not limited to assumptions about future cash inflows and outflows, discount rates, and lives of intangible and other assets. Any excess of the purchase consideration over the fair value of the net assets acquired is recognized as goodwill. In cases when we issue stock or cash awards to the shareholders of an acquired business, we must also evaluate whether the awards represent purchase consideration or compensation for post-acquisition services by considering, among other things, whether the vesting of the awards is contingent upon the continued employment of the receiving shareholders. If continued employment is required, the awards are treated as compensation for post-acquisition services and recognized as expense over the requisite service period. During the one-year measurement period following an acquisition, we may record adjustments to the fair value of the assets acquired and liabilities assumed, with a corresponding offset to goodwill. Upon the conclusion of the measurement period, subsequent adjustments, if any, are recorded in our condensed consolidated statements of operations. Acquisition costs, such as legal and consulting fees, are expensed as incurred. Net Loss Per Share Attributable to Common Stockholders Basic and diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net loss is allocated between Class A and Class B common stock based on the weighted-average shares outstanding for each class. Diluted net loss per share is the same as basic net loss per share because potentially dilutive common stock equivalents are anti-dilutive when in a net loss position. In a period of net income, diluted net income per share would be calculated by giving effect to all potentially dilutive securities outstanding for the period (including unvested restricted stock units and unexercised stock options under our equity incentive plans, outstanding purchase periods under our employee stock purchase plan, unvested restricted stock awards and early exercised options subject to repurchase, and returnable common stock issued in connection with business acquisitions) using the treasury stock method. For past periods in which our convertible preferred stock was outstanding, we computed net income or loss per share using the two-class method. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. We considered our convertible preferred stock to be a participating security, as holders had non-forfeitable dividend rights in the event of our declaration of a dividend for shares of common stock. Our convertible preferred stock did not contractually require holders to participate in our losses. As such, net loss for the periods presented was not allocated to our convertible preferred stock. Recently Adopted Accounting Pronouncements As an emerging growth company, the Jumpstart Our Business Startups Act (the “JOBS Act”) allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. We have elected to use this extended transition period. In October 2021, the Financial Accounting Standards Board (the "FASB ") issued Accounting Standards Update ("ASU ). No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , to amend the current accounting guidance in ASC 805 to require entities to apply ASC 606 to recognize and measure contract assets and contract liabilities acquired in a business combination. We early adopted ASU No. 2021-08 on a prospective basis on February 1, 2022, and the adoption did not have a material impact on our condensed consolidated financial statements. Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes , which is intended to simplify various aspects related to accounting for income taxes. ASU No. 2019-12 removes certain exceptions associated with (1) intraperiod tax allocations, (2) recognition of deferred tax liabilities for equity method investments of foreign subsidiaries, and (3) the calculation of income taxes in an interim period when in a loss position within the framework of ASC 740. ASU No. 2019-12 also clarifies and amends existing guidance to improve consistent application. ASU No. 2019-12 is effective for us for the current annual period and for interim periods in fiscal 2024. The adoption will not have a material impact on our consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to amend the current accounting guidance which requires the measurement of all expected losses to be based on historical experience, current conditions, and reasonable and supportable forecasts. For trade receivables, contract assets, and other financial instruments, we will be required to use a forward-looking expected loss model that reflects probable losses rather than the incurred loss model for recognizing credit losses. ASU No. 2016-13 will be effective for us beginning February 1, 2023. We plan to adopt the guidance on a modified retrospective basis and do not expect the adoption to have a material impact on our consolidated financial statements.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended October 31, 2022 2021 Amount Percentage of Amount Percentage of Americas (1) $ 147,312 56 % $ 111,302 50 % Europe, Middle East, and Africa 65,880 25 % 63,333 29 % Asia-Pacific (2) 49,552 19 % 46,181 21 % Total revenue $ 262,744 100 % $ 220,816 100 % (1) Revenue from the United States represented 52% and 44% of our total revenues for the three months ended October 31, 2022 and 2021, respectively. (2) Revenue from Japan represented 7% and 9% of our total revenues for the three months ended October 31, 2022 and 2021, respectively. Nine Months Ended October 31, 2022 2021 Amount Percentage of Amount Percentage of Americas (1) $ 382,440 51 % $ 285,194 47 % Europe, Middle East, and Africa 205,004 27 % 173,822 29 % Asia-Pacific (2) 162,588 22 % 143,538 24 % Total revenue $ 750,032 100 % $ 602,554 100 % (1) Revenue from the United States represented 47% and 42% of our total revenues for the nine months ended October 31, 2022 and 2021, respectively. (2) Revenue from Japan represented 10% and 12% of our total revenues for the nine months ended October 31, 2022 and 2021, respectively. Deferred Revenue During the nine months ended October 31, 2022 and 2021, we recognized $268.8 million and $179.3 million of revenue that was included in the deferred revenue balance as of January 31, 2022 and 2021, respectively . Remaining Performance Obligations Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of October 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $759.1 million, which consists of $396.0 million of billed consideration and $363.1 million of unbilled consideration. We expect to recognize 58% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter. Deferred Contract Acquisition Costs Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $16.1 million and $8.9 million for the three months ended October 31, 2022 and 2021, respectively, and $38.0 million and $19.9 million for the nine months ended October 31, 2022 and 2021, respectively.

Marketable Securities

Marketable Securities	9 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The following is a summary of our marketable securities (in thousands): As of October 31, 2022 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 50,288 $ — $ — $ 50,288 Treasury bills (1) 107,722 — (223) 107,499 Corporate bonds 56,701 — (501) 56,200 Municipal and agency bonds 14,730 — (192) 14,538 Total marketable securities $ 229,441 $ — $ (916) $ 228,525 (1) Additional treasury bills with amortized cost of $89.7 million and estimated fair value of $89.6 million are included in cash and cash equivalents due to their original maturities of three months or less. As of January 31, 2022 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 15,343 $ — $ — $ 15,343 Corporate bonds 91,735 — (303) 91,432 Municipal and agency bonds 9,197 — (32) 9,165 Total marketable securities $ 116,275 $ — $ (335) $ 115,940 As of October 31, 2022 and January 31, 2022, respectively $2.9 million and $19.5 million of our marketable securities had remaining contractual maturities of one year or more, and the remainder had contractual maturities of less than one year. To determine whether any decline in the fair value of our marketable securities is other-than temporary, we evaluate, among other factors, the duration and extent to which the fair value has been less than the carrying value and our intent and ability to retain the marketable securities for a period of time sufficient to allow for any anticipated recovery in fair value. Based on available evidence, we concluded that the gross unrealized losses on our marketable securities as of October 31, 2022 and January 31, 2022 are temporary in nature.

Fair Value Measurement

Fair Value Measurement	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of October 31, 2022 and January 31, 2022 (in thousands): As of October 31, 2022 Level 1 Level 2 Total Financial assets: Money market $ 411,906 $ — $ 411,906 Treasury bills 89,611 — 89,611 Total cash equivalents 501,517 — 501,517 Commercial paper — 50,288 50,288 Treasury bills 107,499 — 107,499 Corporate bonds — 56,200 56,200 Municipal and agency bonds — 14,538 14,538 Total marketable securities 107,499 121,026 228,525 Total $ 609,016 $ 121,026 $ 730,042 As of January 31, 2022 Level 1 Level 2 Total Financial assets: Money market $ 1,056,555 $ — $ 1,056,555 Total cash equivalents 1,056,555 — 1,056,555 Commercial paper — 15,343 15,343 Corporate bonds — 91,432 91,432 Municipal and agency bonds — 9,165 9,165 Total marketable securities — 115,940 115,940 Total $ 1,056,555 $ 115,940 $ 1,172,495 Our money market funds and treasury bills are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper, corporate bonds, and municipal and agency bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded. None of our financial instruments were classified in the Level 3 category as of October 31, 2022 or January 31, 2022.

Business Acquisitions

Business Acquisitions	9 Months Ended
	Oct. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Acquisitions	Business Acquisitions Re:infer On July 29, 2022, we acquired all of the outstanding capital stock of Re:infer LTD. (“Re:infer”), a natural language processing company focused on unstructured documents and communications. Re:infer uses machine learning technology to mine context from communication messages and transform them into actionable data. With this acquisition, UiPath gains technology and an experienced team which we believe will accelerate our technology roadmap, expand the breadth of our current AI-powered automation capabilities, and unlock new automation opportunities for our customers. The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following: Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note to be paid on first anniversary of closing (included in accrued expenses and other current liabilities) 5,863 Loan note to be paid on second anniversary of closing (included in other liabilities, non-current) 5,570 Working capital adjustment 66 Total $ 44,581 At closing, we also issued an additional 0.4 million shares of Class A common stock that will be released to sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to certain employment-related clawback provisions. The aggregate fair value of these shares totaled $7.6 million and will be expensed as compensation for post-acquisition services over the three years following the acquisition date. During the nine months ended October 31, 2022, we incurred transaction costs in connection with the Re:infer acquisition of $1.1 million, which are included in general and administrative expenses in the condensed consolidated statements of operations. The Re:infer acquisition was accounted for as a business combination. The purchase price has been allocated to identifiable intangible assets of $13.1 million (consisting of developed technology with a fair value of $10.0 million and estimated useful life of five years and customer relationships with a fair value of $3.1 million and estimated useful life of three years), deferred tax liabilities of $3.2 million (included in other liabilities, non-current on the condensed consolidated balance sheet), other net tangible assets of $0.3 million, and goodwill of $34.4 million representing expected synergies and acquired skilled workforce. None of this goodwill is deductible for tax purposes. Cloud Elements On March 19, 2021, we acquired all of the outstanding capital stock of Cloud Elements Inc. ("Cloud Elements"), provider of an application programming interface ("API") integration platform for SaaS application providers. The total purchase consideration was $36.1 million, consisting of $5.7 million in cash and $30.4 million in fair value of common stock.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets, Net Acquired intangible assets, net consisted of the following as of October 31, 2022 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 26,950 $ (9,067) $ 17,883 3.8 Customer relationships 7,941 (2,897) 5,044 2.2 Trade names and trademarks 267 (219) 48 1.4 Other intangibles 1,231 (213) 1,018 7.8 Total $ 36,389 $ (12,396) $ 23,993 Acquired intangible assets, net consisted of the following as of January 31, 2022 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 18,627 $ (6,584) $ 12,043 3.4 Customer relationships 5,010 (1,479) 3,531 2.2 Trade names and trademarks 274 (185) 89 1.9 Other intangibles 1,231 (77) 1,154 8.3 Total $ 25,142 $ (8,325) $ 16,817 We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, customer relationships in sales and marketing expense, trade names and trademarks in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets for the three months ended October 31, 2022 and 2021 was $2.1 million and $1.4 million, respectively. Amortization of acquired intangible assets for the nine months ended October 31, 2022 and 2021 was $4.8 million and $3.7 million, respectively. Expected future amortization expense related to intangible assets was as follows as of October 31, 2022 (in thousands): Amount Remainder of year ending January 31, 2023 $ 2,044 Year ending January 31, 2024 8,174 2025 6,263 2026 3,873 2027 2,264 Thereafter 1,375 Total $ 23,993 Goodwill Changes in the carrying amount of goodwill during the nine months ended October 31, 2022 were as follows (in thousands): Carrying Balance as of January 31, 2022 $ 53,564 Acquisition of Re:infer 34,351 Effect of foreign currency translation (4,071) Balance as of October 31, 2022 $ 83,844

Operating Leases

Operating Leases	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Operating Leases	Operating Leases Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 15 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees. Lease costs are presented below (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Operating lease cost $ 3,060 $ 2,433 $ 8,555 $ 6,013 Short-term lease cost 1,509 1,133 4,552 2,989 Variable lease cost 362 139 885 413 Sublease income (1) (532) — (1,597) — Total $ 4,399 $ 3,705 $ 12,395 $ 9,415 (1) Included in other income (expense), net in the condensed consolidated statements of operations. The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of October 31, 2022 January 31, 2022 Weighted-average remaining lease term (years) 12.4 13.7 Weighted-average discount rate 6.7 % 6.5 % Future undiscounted lease payments for our operating lease liabilities as of October 31, 2022 were as follows (in thousands): Amount Remainder of year ending January 31, 2023 $ 1,405 Year ending January 31, 2024 11,755 2025 9,023 2026 6,902 2027 6,591 Thereafter 55,656 Total operating lease payments 91,332 Less: imputed interest (29,839) Total operating lease liabilities $ 61,493 As of October 31, 2022, we had non-cancellable commitments in the amount of $1.9 million related to operating leases of real estate facilities that have not yet commenced. Current operating lease liabilities of $6.4 million and $1.6 million were included in accrued expenses and other current liabilities Supplemental cash flow information related to leases for the three and nine months ended October 31, 2022 and 2021 was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 1,721 $ 1,606 $ 5,278 $ 5,457 Operating lease ROU assets obtained in exchange for new operating lease liabilities 5,769 33,492 8,659 35,082

Condensed Consolidated Balanc_3

Condensed Consolidated Balance Sheet Components	9 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Balance Sheet Components	Condensed Consolidated Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): As of October 31, 2022 January 31, 2022 Prepaid expenses $ 31,210 $ 29,451 Value-added taxes receivable 3,619 3,313 Other receivables 23,590 6,762 Supplier advances and prepaid service credits 16,415 15,890 Prepaid expenses and other current assets $ 74,834 $ 55,416 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of October 31, 2022 January 31, 2022 Computers and equipment $ 26,627 $ 22,478 Leasehold improvements 16,844 9,338 Furniture and fixtures 5,664 4,875 Construction in progress 3,996 2,552 Property and equipment, gross 53,131 39,243 Less: accumulated depreciation (24,979) (22,067) Property and equipment, net $ 28,152 $ 17,176 Depreciation expense for the three months ended October 31, 2022 and 2021 was $2.2 million and $1.7 million, respectively. Depreciation expense for the nine months ended October 31, 2022 and 2021 was $6.0 million and $5.2 million, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of October 31, 2022 January 31, 2022 Accrued expenses $ 21,873 $ 21,736 Withholding tax from employee equity transactions 2,529 16,618 Employee stock purchase plan withholdings 8,365 4,302 Payroll taxes and other benefits payable 6,684 7,016 Income tax payable 13,309 18,210 Value-added taxes payable 3,808 9,327 Operating lease liabilities, current 6,408 1,552 Other 15,916 9,197 Accrued expenses and other current liabilities $ 78,892 $ 87,958

Credit Facility

Credit Facility	9 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Credit Facility	Credit Facility On October 30, 2020, we entered into a $200.0 million senior secured revolving credit facility (the “Credit Facility”) with HSBC Ventures USA Inc., Silicon Valley Bank, Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD, maturing October 30, 2023. The Credit Facility contains certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions. We may use the proceeds of future borrowings under the Credit Facility for refinancing other indebtedness, working capital, capital expenditures and other general corporate purposes, including permitted business acquisitions. Our obligations under the Credit Facility are secured by substantially all of our assets, except for our intellectual property. As of October 31, 2022 and January 31, 2022, there were no amounts outstanding under the Credit Facility.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Letters of Credit We had a total of $5.3 million in letters of credit outstanding in favor of certain landlords for office space and for credit line facilities as of October 31, 2022 and January 31, 2022. These letters of credit renew annually and expire on various dates through fiscal year 2024. Indemnification In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, investors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties. These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of October 31, 2022 and January 31, 2022, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote. Restructuring On June 24, 2022, our board of directors approved restructuring actions to manage our operating expenses by reducing our global workforce by approximately 5%. The workforce reduction aimed to simplify our go-to-market approach starting with an alignment expected to result in better market segmentation, higher sales productivity, and best-in-class customer experience and outcomes. In connection with these workforce reductions, we also ceased use of our office in Brooklyn, NY. For the nine months ended October 31, 2022, we incurred $13.1 million of expense related to our restructuring actions, of which $12.0 million relates to employee termination benefits and $1.1 million relates to lease abandonment costs. The following table shows the total amount incurred and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of October 31, 2022 (in thousands): Employee Termination Benefits Accrued restructuring costs as of January 31, 2022 $ — Restructuring costs incurred during the nine months ended October 31, 2022 12,038 Amount paid during the nine months ended October 31, 2022 (11,438) Accrued restructuring costs as of October 31, 2022 $ 600 The following table shows the total restructuring costs incurred during the nine months ended October 31, 2022 (in thousands): Employee Termination Benefits Lease Exit Costs Total Restructuring Costs Cost of subscription services revenue $ 40 $ 97 $ 137 Cost of professional services and other revenue 205 115 320 Sales and marketing 10,758 485 11,243 Research and development — 43 43 General and administrative 1,035 347 1,382 Total $ 12,038 $ 1,087 $ 13,125 On November 10, 2022, our board of directors approved further restructuring actions that are expected to reduce our global workforce across functions by an additional 6%. We expect to substantially complete these actions and recognize related restructuring costs, consisting predominantly of employee termination benefits and contractual changes, by the end of fiscal 2023. Defined Contribution Plans We sponsor defined contribution plans for qualifying employees, including a 401(k) Plan in the United States to which we make matching contributions of 50% of participating employee contributions. Our total matching contribution to the 401(k) Plan was $1.7 million and $1.4 million for the three months ended October 31, 2022 and 2021, respectively, and $8.3 million and $6.1 million for the nine months ended October 31, 2022 and 2021, respectively. Litigation From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters, which arise in the ordinary course of business. In accordance with ASC 450, Contingencies , we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. We are not presently a party to any litigation the outcome of which we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows, or financial condition. We have determined that the existence of a material loss is neither probable nor reasonably possible. Warranty We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made. Non-Cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services and software products and services. During the nine months ended October 31, 2022, we made commitments to purchase $138.1 million of cloud infrastructure services from a third-party vendor and $82.5 million of service credits toward professional services from third-party alliance partners, which together constitute the majority of the increase in our non-cancelable purchase commitments during the period. As of October 31, 2022, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2023 $ 45,817 Year ending January 31, 2024 94,057 2025 75,896 2026 37,876 2027 4,726 Thereafter — Total $ 258,372

Convertible Preferred Stock and

Convertible Preferred Stock and Stockholders' Equity (Deficit)	9 Months Ended
	Oct. 31, 2022
Equity [Abstract]
Convertible Preferred Stock and Stockholders’ Equity (Deficit)	Convertible Preferred Stock and Stockholders’ Equity (Deficit) Convertible Preferred Stock In February 2021, we issued to certain investors approximately 12.0 million shares of Series F convertible preferred stock at a purchase price of $62.28 per share, for an aggregate purchase price of $750.0 million. Immediately prior to the completion of the IPO, all convertible preferred stock outstanding, totaling approximately 306.3 million shares, was automatically converted into an equivalent number of shares of Class A common stock on a one-to-one basis and its carrying value of $1,971.8 million was reclassified to stockholders’ equity. No convertible preferred stock was outstanding as of October 31, 2022 and January 31, 2022, respectively. Preferred Stock In April 2021, we amended and restated our certificate of incorporation, which authorized 20.0 million shares of preferred stock. Common Stock In April 2021, we amended and restated our certificate of incorporation, which authorized a total of 2.0 billion shares of Class A common stock and 115.7 million shares of Class B common stock. Each share of Class B common stock will convert automatically into Class A common stock, on a one-to-one basis, upon certain circumstances, including: (1) the sale or transfer of such share of Class B common stock (except under certain circumstances described in the amended and restated certificate of incorporation), (2) a date fixed by the board of directors that is no less than 120 days and no more than 180 days following the date that the number of shares of Class B common stock outstanding is less than 20% of the number of shares of Class B common stock outstanding immediately prior to the completion of the IPO, or (3) six months after the death or incapacity of Daniel Dines. The Class A common stock is entitled to one vote per share and the Class B common stock is entitled to thirty-five votes per share. We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. During the nine months ended October 31, 2022, we contributed 0.3 million shares of our Class A common stock to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair value of the shares on the contribution date of $5.5 million was recorded within general and administrative expense in the condensed consolidated statements of operations. Accumulated Other Comprehensive Income (Loss) For the nine months ended October 31, 2022 and 2021, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive loss, net of tax (3,321) (625) (3,946) Balance as of October 31, 2022 $ 7,913 $ (960) $ 6,953 Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2021 $ (12,504) $ (17) $ (12,521) Other comprehensive income (loss), net of tax 16,424 (72) 16,352 Balance as of October 31, 2021 $ 3,920 $ (89) $ 3,831

Equity Incentive Plans and Stoc

Equity Incentive Plans and Stock-Based Compensation	9 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans and Stock-Based Compensation	Equity Incentive Plans and Stock-Based Compensation 2021 Stock Plan In April 2021, prior to and in connection with the IPO, we adopted our 2021 Stock Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards ("RSAs"), restricted stock units ("RSUs"), performance awards, and other forms of awards. As of October 31, 2022, we have reserved 145.9 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase. 2021 Employee Stock Purchase Plan In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of October 31, 2022, the ESPP authorizes the issuance of 15.9 million shares of our Class A common stock under purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (1) 85% of the fair market value of our Class A common stock as of the commencement of each offering period, and (2) 85% of the fair market value of our Class A common stock on the corresponding purchase date. Stock Options Stock option activity during the nine months ended October 31, 2022 was as follows: Stock Weighted- Weighted-Average Aggregate Outstanding as of January 31, 2022 14,544 $ 1.64 7.6 $ 507,419 Granted 4,727 $ 7.02 Exercised (3,788) $ 1.97 Forfeited (818) $ 3.17 Outstanding as of October 31, 2022 14,665 $ 3.21 7.8 $ 144,761 Vested and exercisable as of October 31, 2022 6,854 $ 1.56 6.2 $ 75,985 The weighted-average grant date fair value of stock options granted during the nine months ended October 31, 2022 was $12.17 per share. The intrinsic value of stock options exercised during the nine months ended October 31, 2022 was $72.4 million Unrecognized compensation expense associated with unvested stock options granted and outstanding as of October 31, 2022, was $135.5 million, which is to be recognized over a weighted-average remaining period of 2.9 years. Early Exercised Options Certain stock option holders have the right to early exercise unvested options, subject to a repurchase right held by us at the original exercise price in the event of voluntary or involuntary termination of employment of the option holders. During the nine months ended October 31, 2022, we repurchased 0.4 million unvested early exercised options in the amount of $1.5 million. Cash proceeds associated with early exercised options are recorded within accrued expenses and other current liabilities and other liabilities, non-current in our condensed consolidated balance sheets, depending upon the future vesting dates of the associated options. Such accrued amounts were not material and $2.8 million as of October 31, 2022 and January 31, 2022, respectively. Proceeds are transferred to additional paid-in capital at the time of option vesting. Restricted Stock Units RSU activity during the nine months ended October 31, 2022 was as follows: RSUs (in thousands) Weighted-Average Grant Unvested as of January 31, 2022 27,515 $ 35.35 Granted 26,182 $ 16.16 Vested (1) (9,479) $ 29.32 Forfeited (5,416) $ 35.19 Unvested as of October 31, 2022 38,802 $ 23.74 (1) Class A common stock has not been issued in connection with 6 vested RSUs because such RSUs were unsettled as of October 31, 2022. The vesting date fair value of RSUs that vested during the nine months ended October 31, 2022 was $173.9 million. Prior to the IPO, we granted RSUs under our 2018 Stock Plan that vested upon the satisfaction of both a service-based condition (generally four years) and a performance-based condition. The performance-based vesting condition was deemed satisfied on April 23, 2021, the date that our IPO was completed. At that time, we recognized $233.0 million of cumulative stock-based compensation expense for the portion of these RSUs for which the service-based vesting condition had been fully or partially satisfied. As of October 31, 2022, total unrecognized compensation expense related to unvested RSUs was approximately $782.8 million, which is to be recognized over a weighted-average remaining period of 2.9 years. Restricted Stock Awards In September 2020, we issued approximately 0.1 million RSAs to a member of our board of directors at a grant date fair value of $33.22 per share, totaling $4.0 million. Such RSAs vest monthly over four years from the grant date. The unvested shares are subject to a repurchase right held by us. As of October 31, 2022, total unrecognized compensation expense related to unvested RSAs was $1.9 million and will be recognized over the remaining vesting period of 1.9 years. Employee Stock Purchase Plan Awards During the nine months ended October 31, 2022, 0.6 million shares were purchased under the ESPP at $15.68 per share. No shares were purchased under the ESPP during the nine months ended October 31, 2021. As of October 31, 2022, total unrecognized compensation expense related to the ESPP was approximately $1.2 million, which is to be recognized over a weighted-average remaining period of 0.1 years. Stock-Based Compensation Associated with Business Acquisition At the closing of the acquisition of Re:infer on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) that will be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of October 31, 2022, total unrecognized compensation expense related to these shares was $7.0 million, which is to be recognized over a weighted-average remaining period of 2.8 years. Stock-Based Compensation Expense Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cost of subscription services revenue $ 2,844 $ 2,045 $ 8,901 $ 9,916 Cost of professional services and other revenue 2,557 4,305 8,959 27,140 Sales and marketing 30,763 41,823 117,410 202,122 Research and development 23,435 24,866 73,559 114,460 General and administrative 21,492 22,064 61,968 84,913 Total $ 81,091 $ 95,103 $ 270,797 $ 438,551 There was no capitalized stock-based compensation relating to software development costs for the three and nine months ended October 31, 2022. The expense presented in the above table is net of capitalized stock-based compensation relating to software development costs of $2.2 million and $4.5 million for the three and nine months ended October 31, 2021, respectively.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesOur tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. We had a provision for income taxes of $1.2 million and $3.1 million for the three months ended October 31, 2022 and 2021, respectively. Our effective tax rate was (2.1%) and (2.6%) for the three months ended October 31, 2022 and 2021, respectively. For the three months ended October 31, 2022 and 2021, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets for losses due to a full valuation allowance and due to tax rate differences between the United States and foreign countries. We had a provision for income taxes of $10.1 million and $6.3 million for the nine months ended October 31, 2022 and 2021, respectively. Our effective tax rate was (3.5%) and (1.4%) for the nine months ended October 31, 2022 and 2021, respectively. For the nine months ended October 31, 2022 and 2021, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets for losses due to a full valuation allowance and due to tax rate differences between the United States and foreign countries. The realization of tax benefits of net deferred tax assets (“DTAs”) is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the nine months ended October 31, 2022, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. may not be realized. Accordingly, we recorded a full valuation allowance against the U.S., Romania, and the U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. As of October 31, 2022, there is no valuation allowance recorded against DTAs associated with Japan, as we believe it is more likely than not that we will realize such assets during the prescribed statutory period. As of October 31, 2022, we had gross unrecognized tax benefits totaling $3.4 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.7 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. The tax positions of UiPath, Inc. and its subsidiaries are subject to income tax audits in multiple tax jurisdictions globally, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. At this time, we do not expect any significant changes in the next 12 months.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Three Months Ended October 31, 2022 2021 Class A Class B Class A Class B Numerator: Net loss $ (49,073) $ (8,651) $ (103,747) $ (19,040) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 467,711 82,453 449,265 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.10) $ (0.10) $ (0.23) $ (0.23) Nine Months Ended October 31, 2022 2021 Class A Class B Class A Class B Numerator: Net loss $ (255,266) $ (45,397) $ (364,403) $ (98,073) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 463,634 82,453 336,301 90,510 Net loss per share attributable to common stockholders, basic and diluted $ (0.55) $ (0.55) $ (1.08) $ (1.08) Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Three Months Ended October 31, 2022 2021 Class A Class B Class A Class B Convertible preferred stock — — — — Unvested RSUs 31,022 — 19,491 — Outstanding stock options 13,812 — 17,308 — Shares subject to repurchase from RSAs and early exercised stock options 104 — 1,260 — Shares issuable under ESPP 936 — 422 — Returnable shares issued in connection with business acquisition 427 — — — Total 46,301 — 38,481 — Nine Months Ended October 31, 2022 2021 Class A Class B Class A Class B Convertible preferred stock — — 90,936 — Unvested RSUs 29,307 — 24,917 — Outstanding stock options 13,913 — 19,664 — Shares subject to repurchase from RSAs and early exercised stock options 355 — 1,729 — Shares issuable under ESPP 851 — 270 — Returnable shares issued in connection with business acquisition 149 — — — Total 44,575 — 137,516 —

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party TransactionsSince the third quarter of fiscal 2022, we have made use of an aircraft owned by Daniel Dines, our Co-Chief Executive Officer, through a special purpose limited liability company in which we have a variable interest. The aircraft is operated by a third-party aircraft management company. Mr. Dines, through the special purpose limited liability company, obtained financing for the aircraft and bears all associated operating, personnel, and maintenance costs. In connection with our business use of the aircraft, we incurred no expenses for the three months ended October 31, 2022 and $1.9 million of expenses for the nine months ended October 31, 2022.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2022, which are included in the 2022 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as the our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its wholly owned subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the nine months ended October 31, 2022 and 2021 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2023 or for any other future interim or annual period.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2023, for example, refer to the fiscal year ending January 31, 2023.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, revenue recognition, estimated expected benefit period for deferred contract acquisition costs, allowance for doubtful accounts, fair value of financial assets, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets, incremental borrowing rates for operating leases, amount of stock-based compensation expense including determination of fair value of common stock prior to our initial public offering ("IPO"), timing and amount of contingencies, costs related to our restructuring actions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency	Foreign CurrencyThe functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations.
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of October 31, 2022 and January 31, 2022, 99% and 96%, respectively, of our cash and cash equivalents were concentrated in the United States, European Union (“EU”) countries, and Japan. We extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures.
Internal-Use Software	Internal-Use Software Pursuant to Accounting Standards Codification ("ASC") 350-40, Internal Use Software , we capitalize costs incurred to implement cloud computing arrangements that are service contracts and costs incurred to develop internal-use software, which has historically included our SaaS products. ASC 350-40 prescribes capitalization of costs incurred during the application development stage, costs incurred to develop or obtain software that allows for access to or conversion of old data by new systems, and costs incurred in connection with upgrades and enhancements to internal-use software if it is probable that such expenditures will result in additional functionality. These capitalized costs exclude training costs, project management costs, and data migration costs. We evaluate our long-lived assets, including these capitalized costs, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. Beginning in the fourth quarter of fiscal 2022, we began to broadly market on-premises versions of certain of our SaaS products, thereby establishing a pattern of marketing internal-use software and a rebuttable presumption that we intend to market any SaaS products we develop. As a result, our ongoing and future SaaS projects must be accounted for under ASC 985-20, Costs of Software to be Sold, Leased or Marketed , which is discussed below under Software Development Costs . Prior to the fourth quarter of fiscal 2022, costs incurred to develop our SaaS products were capitalized and amortized on a straight-line basis over the product’s estimated useful life of five years; amortization is included in cost of subscription services revenue on the condensed consolidated statements of operations. Capitalized costs included salaries, benefits, and stock-based compensation charges for employees that were directly involved in developing our SaaS products. These capitalized costs are included in other assets, non-current on the condensed consolidated balance sheets. Gross capitalized internal-use software development costs were $7.8 million and $10.1 million as of October 31, 2022 and January 31, 2022, respectively. Related amortization expense was $0.3 million and $0.3 million for the three months ended October 31, 2022 and 2021, respectively. Related amortization expense was $1.0 million and $0.8 million for the nine months ended October 31, 2022 and 2021, respectively. Accumulated amortization was $2.6 million and $1.7 million as of October 31, 2022 and January 31, 2022, respectively. Capitalized costs related to the implementation of cloud computing arrangements that are service contracts are amortized on a straight-line basis over the terms of the associated hosting arrangements and are recorded under operating expenses in the same line item on the condensed consolidated statements of operations as the associated hosting arrangement fees. These gross capitalized costs were $2.1 million and $2.3 million as of October 31, 2022 and January 31, 2022, respectively, and are recorded in other assets, non-current on our condensed consolidated balance sheets. Related amortization expense was $0.1 million and $0.2 million for the
Software Development Costs	Software Development Costs We account for costs incurred to develop software to be licensed in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed
Business Acquisitions	Business Acquisitions Purchase consideration in a business combination is allocated to the assets acquired and liabilities assumed, based on their respective fair values at the date of the acquisition. Determination of the fair value of assets acquired and liabilities assumed relies on management judgments and involves the use of estimates and assumptions, including but not limited to assumptions about future cash inflows and outflows, discount rates, and lives of intangible and other assets. Any excess of the purchase consideration over the fair value of the net assets acquired is recognized as goodwill. In cases when we issue stock or cash awards to the shareholders of an acquired business, we must also evaluate whether the awards represent purchase consideration or compensation for post-acquisition services by considering, among other things, whether the vesting of the awards is contingent upon the continued employment of the receiving shareholders. If continued employment is required, the awards are treated as compensation for post-acquisition services and recognized as expense over the requisite service period. During the one-year measurement period following an acquisition, we may record adjustments to the fair value of the assets acquired and liabilities assumed, with a corresponding offset to goodwill. Upon the conclusion of the measurement period, subsequent adjustments, if any, are recorded in our condensed consolidated statements of operations. Acquisition costs, such as legal and consulting fees, are expensed as incurred.
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders Basic and diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net loss is allocated between Class A and Class B common stock based on the weighted-average shares outstanding for each class. Diluted net loss per share is the same as basic net loss per share because potentially dilutive common stock equivalents are anti-dilutive when in a net loss position. In a period of net income, diluted net income per share would be calculated by giving effect to all potentially dilutive securities outstanding for the period (including unvested restricted stock units and unexercised stock options under our equity incentive plans, outstanding purchase periods under our employee stock purchase plan, unvested restricted stock awards and early exercised options subject to repurchase, and returnable common stock issued in connection with business acquisitions) using the treasury stock method. For past periods in which our convertible preferred stock was outstanding, we computed net income or loss per share using the two-class method. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. We considered our convertible preferred stock to be a participating security, as holders had non-forfeitable dividend rights in the event of our declaration of a dividend for shares of common stock. Our convertible preferred stock did not contractually require holders to participate in our losses. As such, net loss for the periods presented was not allocated to our convertible preferred stock.
Recently Adopted and Recently Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements As an emerging growth company, the Jumpstart Our Business Startups Act (the “JOBS Act”) allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. We have elected to use this extended transition period. In October 2021, the Financial Accounting Standards Board (the "FASB ") issued Accounting Standards Update ("ASU ). No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , to amend the current accounting guidance in ASC 805 to require entities to apply ASC 606 to recognize and measure contract assets and contract liabilities acquired in a business combination. We early adopted ASU No. 2021-08 on a prospective basis on February 1, 2022, and the adoption did not have a material impact on our condensed consolidated financial statements. Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes , which is intended to simplify various aspects related to accounting for income taxes. ASU No. 2019-12 removes certain exceptions associated with (1) intraperiod tax allocations, (2) recognition of deferred tax liabilities for equity method investments of foreign subsidiaries, and (3) the calculation of income taxes in an interim period when in a loss position within the framework of ASC 740. ASU No. 2019-12 also clarifies and amends existing guidance to improve consistent application. ASU No. 2019-12 is effective for us for the current annual period and for interim periods in fiscal 2024. The adoption will not have a material impact on our consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to amend the current accounting guidance which requires the measurement of all expected losses to be based on historical experience, current conditions, and reasonable and supportable forecasts. For trade receivables, contract assets, and other financial instruments, we will be required to use a forward-looking expected loss model that reflects probable losses rather than the incurred loss model for recognizing credit losses. ASU No. 2016-13 will be effective for us beginning February 1, 2023. We plan to adopt the guidance on a modified retrospective basis and do not expect the adoption to have a material impact on our consolidated financial statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Geographical Region	The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended October 31, 2022 2021 Amount Percentage of Amount Percentage of Americas (1) $ 147,312 56 % $ 111,302 50 % Europe, Middle East, and Africa 65,880 25 % 63,333 29 % Asia-Pacific (2) 49,552 19 % 46,181 21 % Total revenue $ 262,744 100 % $ 220,816 100 % (1) Revenue from the United States represented 52% and 44% of our total revenues for the three months ended October 31, 2022 and 2021, respectively. (2) Revenue from Japan represented 7% and 9% of our total revenues for the three months ended October 31, 2022 and 2021, respectively. Nine Months Ended October 31, 2022 2021 Amount Percentage of Amount Percentage of Americas (1) $ 382,440 51 % $ 285,194 47 % Europe, Middle East, and Africa 205,004 27 % 173,822 29 % Asia-Pacific (2) 162,588 22 % 143,538 24 % Total revenue $ 750,032 100 % $ 602,554 100 % (1) Revenue from the United States represented 47% and 42% of our total revenues for the nine months ended October 31, 2022 and 2021, respectively. (2) Revenue from Japan represented 10% and 12% of our total revenues for the nine months ended October 31, 2022 and 2021, respectively.

Marketable Securities (Tables)

Marketable Securities (Tables)	9 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	The following is a summary of our marketable securities (in thousands): As of October 31, 2022 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 50,288 $ — $ — $ 50,288 Treasury bills (1) 107,722 — (223) 107,499 Corporate bonds 56,701 — (501) 56,200 Municipal and agency bonds 14,730 — (192) 14,538 Total marketable securities $ 229,441 $ — $ (916) $ 228,525 (1) Additional treasury bills with amortized cost of $89.7 million and estimated fair value of $89.6 million are included in cash and cash equivalents due to their original maturities of three months or less. As of January 31, 2022 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 15,343 $ — $ — $ 15,343 Corporate bonds 91,735 — (303) 91,432 Municipal and agency bonds 9,197 — (32) 9,165 Total marketable securities $ 116,275 $ — $ (335) $ 115,940

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis	The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of October 31, 2022 and January 31, 2022 (in thousands): As of October 31, 2022 Level 1 Level 2 Total Financial assets: Money market $ 411,906 $ — $ 411,906 Treasury bills 89,611 — 89,611 Total cash equivalents 501,517 — 501,517 Commercial paper — 50,288 50,288 Treasury bills 107,499 — 107,499 Corporate bonds — 56,200 56,200 Municipal and agency bonds — 14,538 14,538 Total marketable securities 107,499 121,026 228,525 Total $ 609,016 $ 121,026 $ 730,042 As of January 31, 2022 Level 1 Level 2 Total Financial assets: Money market $ 1,056,555 $ — $ 1,056,555 Total cash equivalents 1,056,555 — 1,056,555 Commercial paper — 15,343 15,343 Corporate bonds — 91,432 91,432 Municipal and agency bonds — 9,165 9,165 Total marketable securities — 115,940 115,940 Total $ 1,056,555 $ 115,940 $ 1,172,495

Business Acquisitions (Tables)

Business Acquisitions (Tables)	9 Months Ended
	Oct. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Total Purchase Consideration	The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following: Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note to be paid on first anniversary of closing (included in accrued expenses and other current liabilities) 5,863 Loan note to be paid on second anniversary of closing (included in other liabilities, non-current) 5,570 Working capital adjustment 66 Total $ 44,581

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	Acquired intangible assets, net consisted of the following as of October 31, 2022 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 26,950 $ (9,067) $ 17,883 3.8 Customer relationships 7,941 (2,897) 5,044 2.2 Trade names and trademarks 267 (219) 48 1.4 Other intangibles 1,231 (213) 1,018 7.8 Total $ 36,389 $ (12,396) $ 23,993 Acquired intangible assets, net consisted of the following as of January 31, 2022 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 18,627 $ (6,584) $ 12,043 3.4 Customer relationships 5,010 (1,479) 3,531 2.2 Trade names and trademarks 274 (185) 89 1.9 Other intangibles 1,231 (77) 1,154 8.3 Total $ 25,142 $ (8,325) $ 16,817
Schedule of Expected Future Amortization Expenses Related to Intangible Assets	Expected future amortization expense related to intangible assets was as follows as of October 31, 2022 (in thousands): Amount Remainder of year ending January 31, 2023 $ 2,044 Year ending January 31, 2024 8,174 2025 6,263 2026 3,873 2027 2,264 Thereafter 1,375 Total $ 23,993
Schedule of Changes in Carrying Amounts of Goodwill	Changes in the carrying amount of goodwill during the nine months ended October 31, 2022 were as follows (in thousands): Carrying Balance as of January 31, 2022 $ 53,564 Acquisition of Re:infer 34,351 Effect of foreign currency translation (4,071) Balance as of October 31, 2022 $ 83,844

Operating Leases (Tables)

Operating Leases (Tables)	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Schedule of Lease Costs and Supplemental Cash Flow Information	Lease costs are presented below (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Operating lease cost $ 3,060 $ 2,433 $ 8,555 $ 6,013 Short-term lease cost 1,509 1,133 4,552 2,989 Variable lease cost 362 139 885 413 Sublease income (1) (532) — (1,597) — Total $ 4,399 $ 3,705 $ 12,395 $ 9,415 (1) Included in other income (expense), net in the condensed consolidated statements of operations. Supplemental cash flow information related to leases for the three and nine months ended October 31, 2022 and 2021 was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 1,721 $ 1,606 $ 5,278 $ 5,457 Operating lease ROU assets obtained in exchange for new operating lease liabilities 5,769 33,492 8,659 35,082
Schedule of Weighted-average Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of October 31, 2022 January 31, 2022 Weighted-average remaining lease term (years) 12.4 13.7 Weighted-average discount rate 6.7 % 6.5 %
Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities	Future undiscounted lease payments for our operating lease liabilities as of October 31, 2022 were as follows (in thousands): Amount Remainder of year ending January 31, 2023 $ 1,405 Year ending January 31, 2024 11,755 2025 9,023 2026 6,902 2027 6,591 Thereafter 55,656 Total operating lease payments 91,332 Less: imputed interest (29,839) Total operating lease liabilities $ 61,493

Condensed Consolidated Balanc_4

Condensed Consolidated Balance Sheet Components (Tables)	9 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): As of October 31, 2022 January 31, 2022 Prepaid expenses $ 31,210 $ 29,451 Value-added taxes receivable 3,619 3,313 Other receivables 23,590 6,762 Supplier advances and prepaid service credits 16,415 15,890 Prepaid expenses and other current assets $ 74,834 $ 55,416
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of October 31, 2022 January 31, 2022 Computers and equipment $ 26,627 $ 22,478 Leasehold improvements 16,844 9,338 Furniture and fixtures 5,664 4,875 Construction in progress 3,996 2,552 Property and equipment, gross 53,131 39,243 Less: accumulated depreciation (24,979) (22,067) Property and equipment, net $ 28,152 $ 17,176
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of October 31, 2022 January 31, 2022 Accrued expenses $ 21,873 $ 21,736 Withholding tax from employee equity transactions 2,529 16,618 Employee stock purchase plan withholdings 8,365 4,302 Payroll taxes and other benefits payable 6,684 7,016 Income tax payable 13,309 18,210 Value-added taxes payable 3,808 9,327 Operating lease liabilities, current 6,408 1,552 Other 15,916 9,197 Accrued expenses and other current liabilities $ 78,892 $ 87,958

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Accrued Restructuring Costs	The following table shows the total amount incurred and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of October 31, 2022 (in thousands): Employee Termination Benefits Accrued restructuring costs as of January 31, 2022 $ — Restructuring costs incurred during the nine months ended October 31, 2022 12,038 Amount paid during the nine months ended October 31, 2022 (11,438) Accrued restructuring costs as of October 31, 2022 $ 600
Schedule of Restructuring Costs	The following table shows the total restructuring costs incurred during the nine months ended October 31, 2022 (in thousands): Employee Termination Benefits Lease Exit Costs Total Restructuring Costs Cost of subscription services revenue $ 40 $ 97 $ 137 Cost of professional services and other revenue 205 115 320 Sales and marketing 10,758 485 11,243 Research and development — 43 43 General and administrative 1,035 347 1,382 Total $ 12,038 $ 1,087 $ 13,125
Schedule of Non-Cancelable Purchase Obligations	As of October 31, 2022, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2023 $ 45,817 Year ending January 31, 2024 94,057 2025 75,896 2026 37,876 2027 4,726 Thereafter — Total $ 258,372

Convertible Preferred Stock a_2

Convertible Preferred Stock and Stockholders' Equity (Deficit) (Tables)	9 Months Ended
	Oct. 31, 2022
Equity [Abstract]
Schedule of Changes In Components of Accumulated Other Comprehensive Income (Loss)	For the nine months ended October 31, 2022 and 2021, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive loss, net of tax (3,321) (625) (3,946) Balance as of October 31, 2022 $ 7,913 $ (960) $ 6,953 Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2021 $ (12,504) $ (17) $ (12,521) Other comprehensive income (loss), net of tax 16,424 (72) 16,352 Balance as of October 31, 2021 $ 3,920 $ (89) $ 3,831

Equity Incentive Plans and St_2

Equity Incentive Plans and Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	Stock option activity during the nine months ended October 31, 2022 was as follows: Stock Weighted- Weighted-Average Aggregate Outstanding as of January 31, 2022 14,544 $ 1.64 7.6 $ 507,419 Granted 4,727 $ 7.02 Exercised (3,788) $ 1.97 Forfeited (818) $ 3.17 Outstanding as of October 31, 2022 14,665 $ 3.21 7.8 $ 144,761 Vested and exercisable as of October 31, 2022 6,854 $ 1.56 6.2 $ 75,985
Summary of RSU Activity	RSU activity during the nine months ended October 31, 2022 was as follows: RSUs (in thousands) Weighted-Average Grant Unvested as of January 31, 2022 27,515 $ 35.35 Granted 26,182 $ 16.16 Vested (1) (9,479) $ 29.32 Forfeited (5,416) $ 35.19 Unvested as of October 31, 2022 38,802 $ 23.74 (1) Class A common stock has not been issued in connection with 6 vested RSUs because such RSUs were unsettled as of October 31, 2022.
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cost of subscription services revenue $ 2,844 $ 2,045 $ 8,901 $ 9,916 Cost of professional services and other revenue 2,557 4,305 8,959 27,140 Sales and marketing 30,763 41,823 117,410 202,122 Research and development 23,435 24,866 73,559 114,460 General and administrative 21,492 22,064 61,968 84,913 Total $ 81,091 $ 95,103 $ 270,797 $ 438,551

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Three Months Ended October 31, 2022 2021 Class A Class B Class A Class B Numerator: Net loss $ (49,073) $ (8,651) $ (103,747) $ (19,040) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 467,711 82,453 449,265 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.10) $ (0.10) $ (0.23) $ (0.23) Nine Months Ended October 31, 2022 2021 Class A Class B Class A Class B Numerator: Net loss $ (255,266) $ (45,397) $ (364,403) $ (98,073) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 463,634 82,453 336,301 90,510 Net loss per share attributable to common stockholders, basic and diluted $ (0.55) $ (0.55) $ (1.08) $ (1.08)
Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share	Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Three Months Ended October 31, 2022 2021 Class A Class B Class A Class B Convertible preferred stock — — — — Unvested RSUs 31,022 — 19,491 — Outstanding stock options 13,812 — 17,308 — Shares subject to repurchase from RSAs and early exercised stock options 104 — 1,260 — Shares issuable under ESPP 936 — 422 — Returnable shares issued in connection with business acquisition 427 — — — Total 46,301 — 38,481 — Nine Months Ended October 31, 2022 2021 Class A Class B Class A Class B Convertible preferred stock — — 90,936 — Unvested RSUs 29,307 — 24,917 — Outstanding stock options 13,913 — 19,664 — Shares subject to repurchase from RSAs and early exercised stock options 355 — 1,729 — Shares issuable under ESPP 851 — 270 — Returnable shares issued in connection with business acquisition 149 — — — Total 44,575 — 137,516 —

Organization and Description _2

Organization and Description of Business (Details)	Oct. 31, 2022 country performance_obligation
Organization And Description Of Business [Line Items]
Number of countries having legal presence | country	32
Hybrid Solutions
Organization And Description Of Business [Line Items]
Number of performance obligations | performance_obligation	3

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction losses	$ 0.4	$ 6.5	$ 2.6	$ 11.7
Capitalized costs for cloud computing arrangements, amortization expense	0.1	0.2	0.6	0.4
SaaS Product Development
Summary Of Significant Accounting Policies [Line Items]
Capitalized software, estimated useful life						5 years
Capitalized software, amortization expense	0.3	0.3	$ 1	0.8
Software Development
Summary Of Significant Accounting Policies [Line Items]
Capitalized software, estimated useful life			5 years
Capitalized software, amortization expense	0.2	$ 0.1	$ 0.5	$ 0.6
Other Assets, Noncurrent
Summary Of Significant Accounting Policies [Line Items]
Capitalized costs for cloud computing arrangements, gross	2.1		2.1		$ 2.3
Capitalized costs for cloud computing arrangements, accumulated amortization	1.7		1.7		1.2
Other Assets, Noncurrent | SaaS Product Development
Summary Of Significant Accounting Policies [Line Items]
Capitalized computer software, gross	7.8		7.8		10.1
Capitalized software, accumulated amortization	2.6		2.6		1.7
Other Assets, Noncurrent | Software Development
Summary Of Significant Accounting Policies [Line Items]
Capitalized computer software, gross	4.1		4.1		4.3
Capitalized software, accumulated amortization	$ 1.8		$ 1.8		$ 1.2
Customer Concentration Risk | Accounts Receivable | Customer A
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			11%
United States, European Union (“EU”) Countries, and Japan | Geographic Concentration Risk | Cash and Cash Equivalents
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			99%		96%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 262,744	$ 220,816	$ 750,032	$ 602,554
Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100%	100%	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Total revenue	$ 147,312	$ 111,302	$ 382,440	$ 285,194
Americas | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	56%	50%	51%	47%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Total revenue	$ 65,880	$ 63,333	$ 205,004	$ 173,822
Europe, Middle East, and Africa | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	25%	29%	27%	29%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 49,552	$ 46,181	$ 162,588	$ 143,538
Asia-Pacific | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	19%	21%	22%	24%
United States | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	52%	44%	47%	42%
Japan | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	7%	9%	10%	12%

Revenue Recognition - Deferred

Revenue Recognition - Deferred Revenue and Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized			$ 268,800	$ 179,300
Deferred contract acquisition costs	$ 16,100	$ 8,900	$ 37,967	$ 19,904

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Oct. 31, 2022 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 759.1
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	396
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 363.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-11-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	58%
Remaining performance obligations, period	12 months

Marketable Securities - Summary

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 229,441	$ 116,275
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(916)	(335)
Estimated Fair Value	228,525	115,940
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	50,288	15,343
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	50,288	15,343
Treasury bills
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	107,722
Gross Unrealized Gains	0
Gross Unrealized Losses	(223)
Estimated Fair Value	107,499
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	56,701	91,735
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(501)	(303)
Estimated Fair Value	56,200	91,432
Municipal and agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	14,730	9,197
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(192)	(32)
Estimated Fair Value	14,538	$ 9,165
Cash and cash equivalents | Treasury bills
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	89,700
Estimated Fair Value	$ 89,600

Marketable Securities - Additio

Marketable Securities - Additional Information (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 2,920	$ 19,523

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($)	Oct. 31, 2022	Jan. 31, 2022
Financial assets:
Total marketable securities	$ 228,525,000	$ 115,940,000
Commercial paper
Financial assets:
Total marketable securities	50,288,000	15,343,000
Treasury bills
Financial assets:
Total marketable securities	107,499,000
Corporate bonds
Financial assets:
Total marketable securities	56,200,000	91,432,000
Municipal and agency bonds
Financial assets:
Total marketable securities	14,538,000	9,165,000
Recurring
Financial assets:
Total cash equivalents	501,517,000	1,056,555,000
Total marketable securities	228,525,000	115,940,000
Total	730,042,000	1,172,495,000
Recurring | Commercial paper
Financial assets:
Total marketable securities	50,288,000	15,343,000
Recurring | Treasury bills
Financial assets:
Total marketable securities	107,499,000
Recurring | Corporate bonds
Financial assets:
Total marketable securities	56,200,000	91,432,000
Recurring | Municipal and agency bonds
Financial assets:
Total marketable securities	14,538,000	9,165,000
Recurring | Money market
Financial assets:
Total cash equivalents	411,906,000	1,056,555,000
Recurring | Treasury bills
Financial assets:
Total cash equivalents	89,611,000
Recurring | Level 1
Financial assets:
Total cash equivalents	501,517,000	1,056,555,000
Total marketable securities	107,499,000	0
Total	609,016,000	1,056,555,000
Recurring | Level 1 | Commercial paper
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Treasury bills
Financial assets:
Total marketable securities	107,499,000
Recurring | Level 1 | Corporate bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Municipal and agency bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Money market
Financial assets:
Total cash equivalents	411,906,000	1,056,555,000
Recurring | Level 1 | Treasury bills
Financial assets:
Total cash equivalents	89,611,000
Recurring | Level 2
Financial assets:
Total cash equivalents	0	0
Total marketable securities	121,026,000	115,940,000
Total	121,026,000	115,940,000
Recurring | Level 2 | Commercial paper
Financial assets:
Total marketable securities	50,288,000	15,343,000
Recurring | Level 2 | Treasury bills
Financial assets:
Total marketable securities	0
Recurring | Level 2 | Corporate bonds
Financial assets:
Total marketable securities	56,200,000	91,432,000
Recurring | Level 2 | Municipal and agency bonds
Financial assets:
Total marketable securities	14,538,000	9,165,000
Recurring | Level 2 | Money market
Financial assets:
Total cash equivalents	0	0
Recurring | Level 2 | Treasury bills
Financial assets:
Total cash equivalents	0
Recurring | Level 3
Financial assets:
Total	$ 0	$ 0

Business Acquisitions - Summary

Business Acquisitions - Summary of Total Purchase Consideration (Details) - USD ($) $ in Thousands, shares in Millions		9 Months Ended
	Jul. 29, 2022	Oct. 31, 2022	Oct. 31, 2021
Business Acquisition [Line Items]
Loan note to be paid		$ 11,433	$ 0
Working capital adjustment	$ 66
Re:infer
Business Acquisition [Line Items]
Cash paid at closing	30,117
Fair value of Class A common stock issued at closing	2,965
Total purchase consideration	$ 44,581
Stock issued at closing (in shares)	0.2
Re:infer | Accrued expenses and other current liabilities
Business Acquisition [Line Items]
Loan note to be paid	$ 5,863
Re:infer | Other liabilities, non-current
Business Acquisition [Line Items]
Loan note to be paid	$ 5,570

Business Acquisitions - Additio

Business Acquisitions - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions				3 Months Ended	9 Months Ended
	Oct. 31, 2022	Jul. 29, 2022	Mar. 19, 2021	Oct. 31, 2022	Oct. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Provisional purchase price allocation to goodwill	$ 83,844			$ 83,844	$ 83,844	$ 53,564
Re:infer
Business Acquisition [Line Items]
Stock issued at closing subject to clawback provisions (in shares)		0.4
Transaction costs					1,100
Provisional purchase price allocation to identifiable intangible assets	13,100			13,100	13,100
Provisional purchase price allocation allocated to deferred tax liabilities	(3,200)			(3,200)	(3,200)
Provisional purchase price allocation to other net tangible assets	300			300	300
Provisional purchase price allocation to goodwill	34,400			34,400	34,400
Goodwill deductible for tax purposes	0			0	0
Total purchase consideration		$ 44,581
Cash consideration		30,117
Fair value of Class A common stock issued at closing		2,965
Re:infer | Developed technology
Business Acquisition [Line Items]
Provisional purchase price allocation to identifiable finite-lived intangible assets	$ 10,000			10,000	10,000
Weighted average useful life	5 years
Re:infer | Customer relationships
Business Acquisition [Line Items]
Provisional purchase price allocation to identifiable finite-lived intangible assets	$ 3,100			3,100	3,100
Weighted average useful life	3 years
Re:infer | Common Stock
Business Acquisition [Line Items]
Unrecognized compensation expense	$ 7,000	$ 7,600		$ 7,000	$ 7,000
Weighted-average remaining period		3 years		2 years 9 months 18 days
Cloud Elements
Business Acquisition [Line Items]
Total purchase consideration			$ 36,100
Cash consideration			5,700
Fair value of Class A common stock issued at closing			$ 30,400

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Summary of Intangible Assets, Net (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 36,389	$ 25,142
Accumulated Amortization	(12,396)	(8,325)
Intangible Assets, Net	23,993	16,817
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	26,950	18,627
Accumulated Amortization	(9,067)	(6,584)
Intangible Assets, Net	$ 17,883	$ 12,043
Weighted- Average Remaining Useful Life (in years)	3 years 9 months 18 days	3 years 4 months 24 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 7,941	$ 5,010
Accumulated Amortization	(2,897)	(1,479)
Intangible Assets, Net	$ 5,044	$ 3,531
Weighted- Average Remaining Useful Life (in years)	2 years 2 months 12 days	2 years 2 months 12 days
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 267	$ 274
Accumulated Amortization	(219)	(185)
Intangible Assets, Net	$ 48	$ 89
Weighted- Average Remaining Useful Life (in years)	1 year 4 months 24 days	1 year 10 months 24 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(213)	(77)
Intangible Assets, Net	$ 1,018	$ 1,154
Weighted- Average Remaining Useful Life (in years)	7 years 9 months 18 days	8 years 3 months 18 days

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangible assets	$ 2.1	$ 1.4	$ 4.8	$ 3.7

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Summary of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of year ending January 31, 2023	$ 2,044
2024	8,174
2025	6,263
2026	3,873
2027	2,264
Thereafter	1,375
Intangible Assets, Net	$ 23,993	$ 16,817

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2022 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 53,564
Acquisition of Re:infer	34,351
Effect of foreign currency translation	(4,071)
Ending Balance	$ 83,844

Operating Leases - Additional I

Operating Leases - Additional Information (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 1,900
Current operating lease liabilities	$ 6,408	$ 1,552
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Minimum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	15 years

Operating Leases - Summary of L

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Leases [Abstract]
Operating lease cost	$ 3,060	$ 2,433	$ 8,555	$ 6,013
Short-term lease cost	1,509	1,133	4,552	2,989
Variable lease cost	362	139	885	413
Sublease income	(532)	0	(1,597)	0
Total	$ 4,399	$ 3,705	$ 12,395	$ 9,415

Operating Leases - Weighted Ave

Operating Leases - Weighted Average Lease Term and Discount Rate (Details)	Oct. 31, 2022	Jan. 31, 2022
Leases [Abstract]
Weighted-average remaining lease term (years)	12 years 4 months 24 days	13 years 8 months 12 days
Weighted-average discount rate	6.70%	6.50%

Operating Leases - Summary of F

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Leases [Abstract]
Remainder of year ending January 31, 2023	$ 1,405
2024	11,755
2025	9,023
2026	6,902
2027	6,591
Thereafter	55,656
Total operating lease payments	91,332
Less: imputed interest	(29,839)
Total operating lease liabilities	$ 61,493

Operating Leases - Supplemental

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 1,721	$ 1,606	$ 5,278	$ 5,457
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 5,769	$ 33,492	$ 8,659	$ 35,082

Condensed Consolidated Balanc_5

Condensed Consolidated Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses	$ 31,210	$ 29,451
Value-added taxes receivable	3,619	3,313
Other receivables	23,590	6,762
Supplier advances and prepaid service credits	16,415	15,890
Prepaid expenses and other current assets	$ 74,834	$ 55,416

Condensed Consolidated Balanc_6

Condensed Consolidated Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 53,131	$ 39,243
Less: accumulated depreciation	(24,979)	(22,067)
Property and equipment, net	28,152	17,176
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	26,627	22,478
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	16,844	9,338
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,664	4,875
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,996	$ 2,552

Condensed Consolidated Balanc_7

Condensed Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 2.2	$ 1.7	$ 6	$ 5.2

Condensed Consolidated Balanc_8

Condensed Consolidated Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 21,873	$ 21,736
Withholding tax from employee equity transactions	2,529	16,618
Employee stock purchase plan withholdings	8,365	4,302
Payroll taxes and other benefits payable	6,684	7,016
Income tax payable	13,309	18,210
Value-added taxes payable	3,808	9,327
Operating lease liabilities, current	6,408	1,552
Other	15,916	9,197
Accrued expenses and other current liabilities	$ 78,892	$ 87,958

Credit Facility (Details)

Credit Facility (Details) - Senior Secured Credit Facility - HSBC Ventures USA Inc., Silicon Valley Bank, Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD - USD ($)	Oct. 31, 2022	Jan. 31, 2022	Oct. 30, 2020
Line of Credit Facility [Line Items]
Maximum borrowing capacity under credit agreement			$ 200,000,000
Outstanding liability under credit facility	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Nov. 10, 2022	Jun. 24, 2022	Jan. 31, 2022
Restructuring Cost and Reserve [Line Items]
Letters of credit outstanding	$ 5,300		$ 5,300				$ 5,300
Expected percentage reduction of global workforce						5%
Restructuring costs incurred			$ 13,125
Defined contribution plan, percentage of participating employee contributions			50%
Defined contribution plan, contribution cost	1,700	$ 1,400	$ 8,300	$ 6,100
Long-Term Purchase Commitment [Line Items]
Purchase commitment	258,372		258,372
Subsequent Event
Restructuring Cost and Reserve [Line Items]
Expected percentage reduction of global workforce					6%
Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred			12,038
Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred			1,087
Cloud infrastructure services
Long-Term Purchase Commitment [Line Items]
Purchase commitment	138,100		138,100
Service credits
Long-Term Purchase Commitment [Line Items]
Purchase commitment	$ 82,500		$ 82,500

Commitments and Contingencies_2

Commitments and Contingencies - Accrued Restructuring Costs (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2022 USD ($)
Restructuring Reserve [Roll Forward]
Restructuring costs incurred	$ 13,125
Employee Termination Benefits
Restructuring Reserve [Roll Forward]
Accrued restructuring costs, beginning balance	0
Restructuring costs incurred	12,038
Amount paid	(11,438)
Accrued restructuring costs, ending balance	$ 600

Commitments and Contingencies_3

Commitments and Contingencies - Restructuring Costs (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2022 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	$ 13,125
Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	12,038
Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	1,087
Cost of revenue | Subscription services
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	137
Cost of revenue | Subscription services | Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	40
Cost of revenue | Subscription services | Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	97
Cost of revenue | Professional services and other
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	320
Cost of revenue | Professional services and other | Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	205
Cost of revenue | Professional services and other | Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	115
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	11,243
Sales and marketing | Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	10,758
Sales and marketing | Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	485
Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	43
Research and development | Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	0
Research and development | Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	43
General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	1,382
General and administrative | Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	1,035
General and administrative | Lease Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	$ 347

Commitments and Contingencies_4

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of year ending January 31, 2023	$ 45,817
2024	94,057
2025	75,896
2026	37,876
2027	4,726
Thereafter	0
Total	$ 258,372

Convertible Preferred Stock a_3

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Additional Information (Details)		1 Months Ended	3 Months Ended	9 Months Ended
	Apr. 22, 2021 USD ($) shares	Apr. 30, 2021 USD ($) vote shares	Jul. 31, 2022 shares	Oct. 31, 2022 USD ($) shares	Oct. 31, 2021 USD ($)	Jan. 31, 2022 USD ($) shares	Feb. 28, 2021 USD ($) $ / shares shares	Jan. 31, 2021 USD ($) shares
Class of Stock [Line Items]
Convertible preferred stock value | $		$ 0		$ 0		$ 0		$ 1,221,968,000
Convertible preferred stock, shares outstanding (in shares)		0						294,257,000
Preferred stock, shares authorized (in shares)		20,000,000		20,000,000		20,000,000
Common stock, conversion ratio		1
Period for conversion of common stock B into common stock A subsequent to death or incapacity of the Chief Executive Officer		6 months
Charitable contribution recorded as expense | $				$ 5,499,000	$ 0
Minimum
Class of Stock [Line Items]
Number of days fixed for conversion of common stock B into common stock A immediately prior to completion of IPO		120 days
Maximum
Class of Stock [Line Items]
Number of days fixed for conversion of common stock B into common stock A immediately prior to completion of IPO		180 days
Percentage of outstanding shares of common stock required for automatic conversion following date fixed for conversion		20%
Series F Convertible Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued (in shares)							12,000,000
Convertible preferred stock, purchase price (in dollars per share) | $ / shares							$ 62.28
Convertible preferred stock value | $							$ 750,000,000
Convertible preferred stock, shares outstanding (in shares)	306,300,000
Convertible preferred stock, conversion ratio	1
Class A Common Stock
Class of Stock [Line Items]
Reclassifications of convertible preferred stock to stockholders' equity | $	$ 1,971,800,000
Common stock, shares authorized (in shares)		2,000,000,000		2,000,000,000		2,000,000,000
Common stock, voting rights, votes per share | vote		1
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)				2,800,000
Class A Common Stock | Common Stock
Class of Stock [Line Items]
Charitable donation of Class A common stock (in shares)			300,000	300,000
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		115,700,000		115,741,000		115,741,000
Common stock, voting rights, votes per share | vote		35

Convertible Preferred Stock a_4

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Summary of Changes In Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2022	Oct. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,849,549	$ 1,880,194	$ 1,921,917	$ 1,898,953	$ 1,899,541	$ (803,704)	$ 1,921,917	$ (803,704)
Other comprehensive income (loss), net of tax	(4,197)	709	(458)	8,429	3,696	4,227	(3,946)	16,352
Ending balance	1,859,824	1,849,549	1,880,194	1,883,405	1,898,953	1,899,541	1,859,824	1,883,405
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	11,150	10,441	10,899	(4,598)	(8,294)	(12,521)	10,899	(12,521)
Other comprehensive income (loss), net of tax	(4,197)	709	(458)	8,429	3,696	4,227
Ending balance	6,953	$ 11,150	10,441	3,831	$ (4,598)	(8,294)	6,953	3,831
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			11,234			(12,504)	11,234	(12,504)
Other comprehensive income (loss), net of tax							(3,321)	16,424
Ending balance	7,913			3,920			7,913	3,920
Unrealized Loss on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ (335)			$ (17)	(335)	(17)
Other comprehensive income (loss), net of tax							(625)	(72)
Ending balance	$ (960)			$ (89)			$ (960)	$ (89)

Equity Incentive Plans and St_3

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended		3 Months Ended							9 Months Ended
	Jul. 29, 2022	Apr. 23, 2021	Apr. 22, 2021	Sep. 30, 2020	Oct. 31, 2022	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options granted (in dollars per share)												$ 12.17
Intrinsic value of stock options exercised												$ 72,400
Cost not yet recognized for unvested options					$ 135,500	$ 135,500						135,500
Repurchase of unvested early exercised stock options												1,493	$ 0
Stock-based compensation expense					81,091				$ 95,103			270,797	438,551
Restricted stock awards issued, value							$ 1
Capitalized stock-based compensation expenses relating to software development cost					0				$ 2,200			$ 0	$ 4,500
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued at closing subject to clawback provisions (in shares)	400,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period												2 years 10 months 24 days
Early Exercised Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accrued proceeds from unvested early exercised stock options					0	0						$ 0		$ 2,800
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period												2 years 10 months 24 days
Fair value of RSUs vested												$ 173,900
Unrecognized compensation expense					782,800	782,800						$ 782,800
Grant date fair value per share (in dollars per share)												$ 16.16
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period												1 year 10 months 24 days
Award vesting period				4 years
Unrecognized compensation expense					1,900	1,900						$ 1,900
Restricted stock awards issued (in shares)				100,000
Grant date fair value per share (in dollars per share)				$ 33.22
Restricted stock awards issued, value				$ 4,000
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)			15,500,000
Period of shares automatically increase			10 years
Percentage of total number of shares			1%
Number of shares authorized (in shares)			15,900,000
Weighted-average remaining period												1 month 6 days
Unrecognized compensation expense					$ 1,200	$ 1,200						$ 1,200
Shares purchased (in shares)												600,000	0
Purchase price (in dollars per share)					$ 15.68	$ 15.68						$ 15.68
Common Stock | Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period	3 years					2 years 9 months 18 days
Unrecognized compensation expense	$ 7,600				$ 7,000	$ 7,000						$ 7,000
Class A Common Stock | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Repurchase of unvested early exercised stock options (in shares)							441,000					400,000
Restricted stock awards issued (in shares)					2,790,000		3,183,000	3,499,000	8,720,000	2,492,000	389,000
Restricted stock awards issued, value							$ 1
Class A Common Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price			85%
Purchase price of common stock, purchase date, percent of market price			85%
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase			10 years
Percentage of total number of shares			5%
2021 Stock Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)					145,900,000	145,900,000						145,900,000
2018 Stock Plan | Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		4 years
Stock-based compensation expense		$ 233,000

Equity Incentive Plans and St_4

Equity Incentive Plans and Stock-Based Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares
Stock Options
Outstanding, beginning balance (in shares) | shares	14,544
Granted (in shares) | shares	4,727
Exercised (in shares) | shares	(3,788)
Forfeited (in shares) | shares	(818)
Outstanding, ending balance (in shares) | shares	14,665	14,544
Weighted- Average Exercise Price
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 1.64
Granted (in dollars per share) | $ / shares	7.02
Exercised (in dollars per share) | $ / shares	1.97
Forfeited (in dollars per share) | $ / shares	3.17
Outstanding, ending balance (in dollars per share) | $ / shares	$ 3.21	$ 1.64
Vested and exercisable, Number of Stock Options (in shares) | shares	6,854
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share) | $ / shares	$ 1.56
Outstanding, Weighted-Average Remaining Contractual Life (years)	7 years 9 months 18 days	7 years 7 months 6 days
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	6 years 2 months 12 days
Outstanding, Aggregate Intrinsic Value | $	$ 144,761	$ 507,419
Vested and exercisable, Aggregate Intrinsic Value | $	$ 75,985

Equity Incentive Plans and St_5

Equity Incentive Plans and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	9 Months Ended
	Oct. 31, 2022 $ / shares shares
RSUs
Unvested, beginning balance (in shares)	27,515
Granted (in shares)	26,182
Vested (in shares)	(9,479)
Forfeited (in shares)	(5,416)
Unvested, ending balance (in shares)	38,802
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) | $ / shares	$ 35.35
Granted (in dollars per share) | $ / shares	16.16
Vested (in dollars per share) | $ / shares	29.32
Forfeited (in dollars per share) | $ / shares	35.19
Unvested, ending balance (in dollars per share) | $ / shares	$ 23.74
Class A Common Stock
Weighted-Average Grant Date Fair Value Per Share
Vested RSUs that were unsettled (in shares)	6

Equity Incentive Plans and St_6

Equity Incentive Plans and Stock-based Compensation - Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 81,091	$ 95,103	$ 270,797	$ 438,551
Cost of revenue | Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,844	2,045	8,901	9,916
Cost of revenue | Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,557	4,305	8,959	27,140
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	30,763	41,823	117,410	202,122
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	23,435	24,866	73,559	114,460
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 21,492	$ 22,064	$ 61,968	$ 84,913

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Valuation Allowance [Line Items]
Provision for income taxes	$ 1,182	$ 3,139	$ 10,061	$ 6,272
Effective tax rate	(2.10%)	(2.60%)	(3.50%)	(1.40%)
Unrecognized tax benefits which would impact the effective tax rate if recognized	$ 3,400		$ 3,400
Liability pertaining to uncertain tax positions	700		700
Japan
Valuation Allowance [Line Items]
Deferred tax valuation allowance	$ 0		$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2022	Oct. 31, 2021
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (57,724)	$ (120,378)	$ (122,561)	$ (122,787)	$ (100,026)	$ (239,663)	$ (300,663)	$ (462,476)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	550,164			531,718			546,087	426,811
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.10)			$ (0.23)			$ (0.55)	$ (1.08)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	550,164			531,718			546,087	426,811
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.10)			$ (0.23)			$ (0.55)	$ (1.08)
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (49,073)			$ (103,747)			$ (255,266)	$ (364,403)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	467,711			449,265			463,634	336,301
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.10)			$ (0.23)			$ (0.55)	$ (1.08)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	467,711			449,265			463,634	336,301
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.10)			$ (0.23)			$ (0.55)	$ (1.08)
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (8,651)			$ (19,040)			$ (45,397)	$ (98,073)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	82,453			82,453			82,453	90,510
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.10)			$ (0.23)			$ (0.55)	$ (1.08)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	82,453			82,453			82,453	90,510
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.10)			$ (0.23)			$ (0.55)	$ (1.08)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Class A Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	46,301	38,481	44,575	137,516
Class A Common Stock | Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	90,936
Class A Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	31,022	19,491	29,307	24,917
Class A Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	13,812	17,308	13,913	19,664
Class A Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	104	1,260	355	1,729
Class A Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	936	422	851	270
Class A Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	427	0	149	0
Class B Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	0
Class B Common Stock | Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	0
Class B Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	0
Class B Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	0
Class B Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	0
Class B Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	0
Class B Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0	0	0

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2022
Chief Executive Officer
Related Party Transaction [Line Items]
Related party expenses	$ 0	$ 1.9